Swiss Group for Clinical Cancer Research   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Bern Switzerland (1965)

Organization Overview

First Clinical Trial
1993
NCT00002526
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Swiss Group for Clinical Cancer Research | Swiss Group for Clinical Cancer Research (SAKK)